OmniAb (OABI) Total Debt (2021 - 2026)

OmniAb (OABI) reported Total Debt of $1.0 million for Q1 2026, up 183.85% year-over-year from $353000.0 in Q1 2025, and down 4.02% quarter-over-quarter from $1.0 million in Q4 2025.

OmniAb (OABI) Total Debt (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Total Debt data on file, last reported at $1.0 million in Q1 2026.

  • Total Debt for Q1 2026 came in at $1.0 million, up 183.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 183.85% YoY), and the FY2025 annual result was $1.0 million, up 96.61% from the prior year.
  • Total Debt fell to $1.0 million in Q1 2026 per OABI's latest filing, from $1.0 million in the prior quarter.
  • Over five years, Total Debt peaked at $4.0 million in Q4 2022 and troughed at $42631.0 in Q1 2022.
  • A 5-year average of $1.1 million and a median of $891000.0 in 2024 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2022 and 2024: Total Debt soared 1153220.0% in 2022, then tumbled 88.33% in 2024.
  • A 5-year view of Total Debt shows it stood at $4.0 million in 2022, then plunged by 67.6% to $1.3 million in 2023, then sank by 59.25% to $531000.0 in 2024, then surged by 96.61% to $1.0 million in 2025, then retreated by 4.02% to $1.0 million in 2026.
  • Business Quant data shows OABI's Total Debt at $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $719000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 1.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00 Mn
Dec 31, 2025 1.04 Mn
Sep 30, 2025 719,000.00
Jun 30, 2025 1.12 Mn
Mar 31, 2025 353,000.00
Dec 31, 2024 531,000.00
Sep 30, 2024 510,000.00
Jun 30, 2024 328,000.00
Mar 31, 2024 891,000.00
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.75 Mn
Jun 30, 2023 2.81 Mn
Mar 31, 2023 2.47 Mn
Dec 31, 2022 4.02 Mn
Sep 30, 2022 88,294.00
Jun 30, 2022 57,666.00
Mar 31, 2022 42,631.00
Dec 31, 2021 2.54 Mn
Jun 30, 2021 5.00